TSEM TOWER SEMICONDUCTOR LTD
Semiconductors & Related Devices · Nasdaq · SEC CIK 928876 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY9.1%
TTM net income YoY6.1%
TTM EPS YoY4.9%
Revenue 3-yr CAGR-2.3%
Net income 3-yr CAGR-5.9%
Margins
Gross margin23.2%
Operating margin12.4%
Net margin14.1%
FCF margin-3.1%
EBITDA margin31.8%
Returns
ROE7.9%
ROA6.9%
ROIC (approx.)6.5%
Asset turnover0.49x
Leverage & solvency
Liabilities / assets12.6%
Debt / equity0.06x
Current ratio6.48x
Interest coverage53.08x
Cash quality & payout
Operating cash flow / net income1.79x
Accruals ratio-5.5%
Payout ratio—
Capex / revenue28.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $1.57B | $1.44B |
| Cost of revenue | $1.20B | $1.10B |
| Gross profit | $363.85M | $339.44M |
| R&D expense | $86.50M | $79.43M |
| SG&A expense | $83.19M | $74.96M |
| Operating income | $194.17M | $191.31M |
| Interest expense | $3.66M | $4.03M |
| Pretax income | $240.38M | $217.43M |
| Income tax | $21.57M | $10.21M |
| Net income | $220.47M | $207.86M |
| EBITDA | $497.28M | $457.59M |
| EPS (basic) | 1.97 | 1.87 |
| EPS (diluted) | 1.94 | 1.85 |
| Weighted avg. shares (diluted) | 113.60M | 112.34M |
| Balance sheet | ||
| Cash & equivalents | $235.37M | $271.89M |
| Short-term investments | $916.54M | $946.35M |
| Receivables | $222.79M | $211.93M |
| Inventory | $256.86M | $268.30M |
| Current assets | $1.71B | $1.76B |
| PP&E, net | $1.46B | $1.29B |
| Goodwill | $7.00M | $7.00M |
| Intangibles | $1.53M | $3.20M |
| Total assets | $3.32B | $3.08B |
| Current liabilities | $263.75M | $285.06M |
| Short-term debt | $28.11M | $48.38M |
| Long-term debt | $133.41M | $132.44M |
| Total debt | $161.52M | $180.81M |
| Total liabilities | $417.71M | $440.31M |
| Shareholders' equity | $2.92B | $2.65B |
| Net debt | -$73.85M | -$91.08M |
| Shares outstanding | 112.53M | 111.55M |
| Cash flow statement | ||
| Operating cash flow | $395.48M | $448.68M |
| Capital expenditure | $444.43M | $436.15M |
| Free cash flow | -$48.94M | $12.53M |
| Investing cash flow | -$398.09M | -$400.24M |
| Financing cash flow | -$33.35M | -$32.45M |
| Depreciation & amortization | $303.11M | $266.28M |
| Stock-based compensation | $37.77M | $33.84M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.